Management of clinically non-functioning pituitary adenoma.
Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S; French Endocrinology Society non-functioning pituitary adenoma work-group.
Ann Endocrinol (Paris). 2015 Jul;76(3):239-47. doi: 10.1016/j.ando.2015.04.002. Epub 2015 Jun 10.
The Epidemiology of Pituitary Adenomas.
Daly AF, Beckers A.
Endocrinol Metab Clin North Am. 2020 Sep;49(3):347-355. doi: 10.1016/j.ecl.2020.04.002. Epub 2020 Jun 10.
Pituitary Incidentalomas: Best Practices and Looking Ahead.
Giraldi E, Allen JW, Ioachimescu AG.
Endocr Pract. 2023 Jan;29(1):60-68. doi: 10.1016/j.eprac.2022.10.004. Epub 2022 Oct 18.
Pituitary Adenoma "Pneumo-Apoplexy".
Almeida AI, Sousa JM, Sampaio L.
World Neurosurg. 2023 Apr;172:10-11. doi: 10.1016/j.wneu.2023.01.052. Epub 2023 Jan 20.
Pituitary adenomas: an overview.
Lake MG, Krook LS, Cruz SV.
Am Fam Physician. 2013 Sep 1;88(5):319-27.
Pituitary tumour types in dogs and cats.
Sanders K, Galac S, Meij BP.
Vet J. 2021 Apr;270:105623. doi: 10.1016/j.tvjl.2021.105623. Epub 2021 Jan 25.
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management?
Chiloiro S, De Marinis L.
Endocr Metab Immune Disord Drug Targets. 2021;21(10):1744-1759. doi: 10.2174/1871530321666210226152901.
Pituitary-Tumor Endocrinopathies.
Melmed S.
N Engl J Med. 2020 Mar 5;382(10):937-950. doi: 10.1056/NEJMra1810772.
A review of multiomics platforms in pituitary adenoma pathogenesis.
Mouchtouris N, Smit RD, Piper K, Prashant G, Evans JJ, Karsy M.
Front Biosci (Landmark Ed). 2022 Mar 4;27(3):77. doi: 10.31083/j.fbl2703077.
Pituitary adenoma.
Grigsby PW.
Front Radiat Ther Oncol. 2001;35:48-56. doi: 10.1159/000061287.
